These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7119133)

  • 1. Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid.
    Davidson J; Turnbull C
    J Clin Psychopharmacol; 1982 Aug; 2(4):263-6. PubMed ID: 7119133
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
    Giller E; Bialos D; Harkness L; Riddle M
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):44-8. PubMed ID: 6376484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase inhibitors in the treatment of atypical depression.
    Zisook S; Braff DL; Click MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):131-7. PubMed ID: 3889078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report.
    Davidson J; Sullivan JL
    J Clin Psychopharmacol; 1983 Feb; 3(1):42-3. PubMed ID: 6833523
    [No Abstract]   [Full Text] [Related]  

  • 5. Failure of isocarboxazid and haloperidol to alleviate delusional depression in a pilot study.
    Davidson J; Miller R; Wingfield M; Dougherty G
    J Clin Psychopharmacol; 1982 Dec; 2(6):408-11. PubMed ID: 7174864
    [No Abstract]   [Full Text] [Related]  

  • 6. Isocarboxazid. Efficacy and tolerance.
    Davidson J; Turnbull C
    J Affect Disord; 1983 May; 5(2):183-9. PubMed ID: 6222098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of seven antidepressant regimes on appetite, weight and carbohydrate preference.
    Harris B; Young J; Hughes B
    Br J Psychiatry; 1986 May; 148():590-2. PubMed ID: 3779231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of dose in isocarboxazid therapy.
    Davidson J; Turnbull C
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):49-52. PubMed ID: 6735995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant isocarboxazid/mianserin treatment of major depressive disorder.
    Riise IS; Holm P
    J Affect Disord; 1984 Apr; 6(2):175-9. PubMed ID: 6233349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoamine oxidase inhibitor-responsive depression.
    Giller E; Bialos D; Riddle M; Sholomskas A; Harkness L
    Psychiatry Res; 1982 Feb; 6(1):41-8. PubMed ID: 7036196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.
    Major GC; Doucet E; Jacqmain M; St-Onge M; Bouchard C; Tremblay A
    Br J Nutr; 2008 May; 99(5):1157-67. PubMed ID: 17977472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term treatment of depression with isocarboxazide.
    Larsen JK; Rafaelsen OJ
    Acta Psychiatr Scand; 1980 Nov; 62(5):456-63. PubMed ID: 7211430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth deficits and desipramine.
    Holt KG
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1167-8. PubMed ID: 1429424
    [No Abstract]   [Full Text] [Related]  

  • 14. Are neurovegetative symptoms stable in relapsing or recurrent atypical depressive episodes?
    Nierenberg AA; Pava JA; Clancy K; Rosenbaum JF; Fava M
    Biol Psychiatry; 1996 Oct; 40(8):691-6. PubMed ID: 8894060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reappearance of a monamine oxidase inhibitor (isocarboxazid).
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1999 Apr; 19(2):105-6. PubMed ID: 10211910
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between dextromethorphan and monoamine oxidase inhibitor therapy with isocarboxazid.
    Sovner R; Wolfe J
    N Engl J Med; 1988 Dec; 319(25):1671. PubMed ID: 3200285
    [No Abstract]   [Full Text] [Related]  

  • 17. Appetite stimulation and weight gain with cyproheptadine. A double-blind study in underweight children.
    Sanzgiri RR; Mohamad HA; Raja Z
    J Postgrad Med; 1970 Jan; 16(1):12-5. PubMed ID: 4913983
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of isocarboxazid in hypertensive patients.
    Drapkin A; Goldberger E
    J New Drugs; 1966; 6(4):237-42. PubMed ID: 5338656
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of conjugated linoleic acid supplementation after weight loss on appetite and food intake in overweight subjects.
    Kamphuis MM; Lejeune MP; Saris WH; Westerterp-Plantenga MS
    Eur J Clin Nutr; 2003 Oct; 57(10):1268-74. PubMed ID: 14506488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of two doses of isocarboxazid in depression.
    Davidson J; Miller R; Turnbull CD; Belyea M; Strickland R
    J Affect Disord; 1984 Apr; 6(2):201-7. PubMed ID: 6233352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.